EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Early FMT for C.Difficile

Phase 1

Completed

Conditions: Clostridium Difficile

Interventions: Procedure: Fecal microbiota transplant (FMT)
Device: flexible sigmoidoscopy

First Posted Date: 2015-06-08

Last Posted Date: 2018-01-31

Lead Sponsor: Emory University

Target Recruit Count: 13

Registration Number: NCT02465463

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke

Not Applicable

Terminated

Conditions: Cerebrovascular Stroke

Interventions: Device: Transcranial Magnetic Stimulation
Device: Traditional Paired Associative Stimulation
Device: Median Nerve Stimulation
Device: Corticocortical Paired Associative Stimulation
Device: Sham Paired Associative Stimulation

First Posted Date: 2015-06-08

Last Posted Date: 2021-11-26

Lead Sponsor: Emory University

Target Recruit Count: 45

Registration Number: NCT02465034

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Wesley Woods Center, Atlanta, Georgia, United States

Stimulus-Stimulus Pairing Study

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Stimulus-stimulus pairing
Other: Vocal recorder

First Posted Date: 2015-06-08

Last Posted Date: 2016-07-15

Lead Sponsor: Emory University

Target Recruit Count: 16

Registration Number: NCT02464527

Locations: 🇺🇸
Marcus Autism Center, Atlanta, Georgia, United States

Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth

Not Applicable

Completed

Conditions: Non-alcoholic Fatty Liver Disease

Interventions: Procedure: Magnetic Resonance Imaging (MRI)

First Posted Date: 2015-06-03

Last Posted Date: 2017-04-10

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT02461212

Locations: 🇺🇸
Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States

Metformin and Congenital Nephrogenic Diabetes Insipidus

Phase 1

Terminated

Conditions: Diabetes Insipidus

Interventions: Drug: Metformin

First Posted Date: 2015-06-02

Last Posted Date: 2018-07-17

Lead Sponsor: Emory University

Target Recruit Count: 2

Registration Number: NCT02460354

Locations: 🇺🇸
Childen's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital - Atlanta Clinical and Translational Science Institute (ACTSI), Atlanta, Georgia, United States

Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes

Phase 4

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Exenatide
Drug: Glargine
Drug: Rapid-acting insulin analogs

First Posted Date: 2015-05-27

Last Posted Date: 2019-06-20

Lead Sponsor: Emory University

Target Recruit Count: 150

Registration Number: NCT02455076

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

Comprehensive HIV Prevention Package for MSM in Port Elizabeth

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: Condom choices
Behavioral: Condom-compatible lubricant choices
Behavioral: Couples HIV counseling and testing (CVCT)
Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
Behavioral: Risk-reduction counseling
Other: HIV Testing
Other: Linkage to care
Procedure: Post-exposure prophylaxis (PEP)

First Posted Date: 2015-05-20

Last Posted Date: 2017-07-06

Lead Sponsor: Emory University

Target Recruit Count: 101

Registration Number: NCT02449733

Locations: 🇿🇦
Human Sciences Research Council, Port Elizabeth, South Africa

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Phase 1

Recruiting

Conditions: Sickle Cell Disease

Interventions: Drug: Arginine
Drug: Arginine (Loading)
Drug: Arginine (Continuous)

First Posted Date: 2015-05-19

Last Posted Date: 2024-06-14

Lead Sponsor: Emory University

Target Recruit Count: 21

Registration Number: NCT02447874

Locations: 🇺🇸
Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States

Testing of Four Home Phenylalanine Monitoring Prototype Devices

Completed

Conditions: Phenylketonurias

First Posted Date: 2015-05-15

Last Posted Date: 2015-12-11

Lead Sponsor: Emory University

Target Recruit Count: 9

Registration Number: NCT02445521

Locations: 🇺🇸
Emory University Hospital - Atlanta Clinical and Translational Science Institute (ACTSI), Atlanta, Georgia, United States
🇺🇸
Emory University Genetics Clinic, Decatur, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia, United States

Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Sitagliptin
Drug: Placebo
Drug: Regular Human Insulin
Drug: Insulin glargine
Drug: Supplemental insulin (Insulin lispro)
Drug: Supplemental insulin (Insulin aspart)

First Posted Date: 2015-05-13

Last Posted Date: 2018-02-06

Lead Sponsor: Emory University

Target Recruit Count: 68

Registration Number: NCT02443402

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital - Midtown, Atlanta, Georgia, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy